• Latest Posts
More News! 22 Nov 2018

First Drug for Rare Inflammation Syndrome Approved by FDA

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche

In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight

This British Biotech is buying its way into the Crowded NASH Space